文献
J-GLOBAL ID:202002291042798813
整理番号:20A0786612
新規miRNA,miR-HCC3によるTNFRSF19とRab43のダウンレギュレーションは肝細胞癌細胞における増殖と上皮間葉転換を促進する【JST・京大機械翻訳】
Downregulation of TNFRSF19 and RAB43 by a novel miRNA, miR-HCC3, promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cells
著者 (9件):
Guo LiMing
(Tianjin Life Science Research Center and Tianjin Key Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China)
,
Gao Rui
(Tianjin Life Science Research Center and Tianjin Key Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China)
,
Gan JianChen
(Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China)
,
Zhu YaNan
(Tianjin Life Science Research Center and Tianjin Key Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China)
,
Ma JunYi
(Tianjin Life Science Research Center and Tianjin Key Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China)
,
Lv Ping
(Tianjin Life Science Research Center and Tianjin Key Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China)
,
Zhang Yi
(Tianjin Life Science Research Center and Tianjin Key Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China)
,
Li ShengPing
(State Key Laboratory of Oncology in Southern China, Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, China)
,
Tang Hua
(Tianjin Life Science Research Center and Tianjin Key Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China)
資料名:
Biochemical and Biophysical Research Communications
(Biochemical and Biophysical Research Communications)
巻:
525
号:
2
ページ:
425-432
発行年:
2020年
JST資料番号:
B0118A
ISSN:
0006-291X
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)